The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis

Document Type : Review Article

Authors

1 Department of Neurosurgery, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, China

2 Department of Acupuncture, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China Department of Neurology, Beijing

3 Department of Neurology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, China

Abstract

The gut-brain axis is a complex communication system between the gut and the brain that has a significant impact on overall health and well-being. Recent evidence suggests that the gut microbiome plays a critical role in this communication system, and that imbalances in the gut microbiome can contribute to the development and progression of neurological disorders. In this comprehensive review, we provide an overview of the gut-brain axis, including the structure and function of the gut microbiome, and the various gut-brain communication pathways. We also discuss the role of dysbiosis, or imbalances in the gut microbiome, in the development and progression of neurological disorders, and the various gut-directed therapies that have been shown to be effective in these conditions, including probiotics, prebiotics, and fecal microbiota transplantation. Finally, we discuss the future directions and challenges in gut-brain research for neurological disorders, including the need for standardized and validated methods for measuring gut microbiome composition and function, and the complex and multi-factorial nature of the gut-brain axis. This review provides a comprehensive overview of the current state of the field and highlights the importance of the gut-brain axis in the management of neurological disorders.

Keywords

Main Subjects

Introduction

The gut-brain axis refers to the complex bidirectional communication between the gut and the central nervous system (CNS) (1). The gut-brain axis involves multiple pathways that include neural, endocrine, and immune signaling mechanisms and plays a critical role in maintaining the homeostasis of the gut and the brain. In recent years, the gut-brain axis has garnered significant attention due to its potential impact on various physiological and pathological processes, including neurological disorders (2).

Neurological disorders encompass a diverse group of conditions that affect the CNS, including the brain and spinal cord. These disorders can manifest as a result of structural or functional changes in the brain, and can present with a wide range of symptoms, including changes in sensation,

 

movement, cognition, and mood (3). The etiology of many neurological disorders is complex and multifactorial, and can involve a combination of genetic, environmental, and lifestyle factors (4).

There is growing evidence to suggest that the gut-brain axis may play a significant role in the development and progression of various neurological disorders. For example, the gut microbiome, which refers to the collection of microorganisms that reside in the gut, has been linked to a range of neurological conditions, including Parkinson's disease, depression, and multiple sclerosis (5, 6). In addition, gut-directed therapies, such as probiotics and prebiotics, have shown promise as potential treatments for neurological disorders.

The purpose of this review is to provide an overview of the gut-brain axis and its significance in the context of neurological disorders. The chapter will outline the components of the gut-brain axis, including the gut microbiome and the pathways of communication between the gut and the brain (7). The review will also examine the current state of research on the role of the gut-brain axis in neurological disorders and the potential for gut-directed therapies as a means of treating these conditions.

In summary, the gut-brain axis represents a complex and dynamic system that plays a critical role in maintaining the health of the gut and the brain. The growing body of evidence linking the gut-brain axis to neurological disorders highlights the importance of further research in this area, and the potential for gut-directed therapies as a means of treating these debilitating conditions.

 

The Gut Microbiome: Structure, Function, and Impact on the Brain

The gut microbiome refers to the complex and diverse community of microorganisms that reside in the gut and play a critical role in human health (8). The gut microbiome is composed of a wide range of microorganisms, including bacteria, viruses, fungi, and archaea, and is an essential component of the gut-brain axis. The structure and function of the gut microbiome is influenced by various factors, including diet, antibiotics, stress, and genetics (9).

The gut microbiome plays a vital role in several physiological processes, including the digestion and absorption of nutrients, the production of short-chain fatty acids, and the maintenance of gut and systemic immunity (10). The gut microbiome also has a profound impact on the brain and behavior, and has been linked to a range of neurological conditions, including depression, anxiety, and autism.

Studies have demonstrated that the gut microbiome can influence the brain through multiple pathways, including the release of neurotransmitters and other signaling molecules, the modulation of the immune system, and the regulation of the hypothalamic-pituitary-adrenal (HPA) axis (11). In addition, the gut microbiome can impact the brain through the production of metabolic by-products, such as short-chain fatty acids and neurotransmitters, and by altering the gut-barrier integrity and permeability, leading to the presence of low-grade inflammation in the body (12).

There is growing evidence to suggest that imbalances in the gut microbiome, also known as dysbiosis, can contribute to the development and progression of neurological disorders. For example, alterations in the gut microbiome have been observed in individuals with depression and anxiety, and the administration of probiotics has been shown to improve symptoms in some patients (13).

In conclusion, the gut microbiome is a complex and dynamic system that plays a critical role in human health. The gut microbiome has a profound impact on the brain and behavior, and imbalances in the gut microbiome, or dysbiosis, can contribute to the development and progression of neurological disorders (14). Further research is needed to better understand the mechanisms by which the gut microbiome influences the brain, and the potential for gut-directed therapies, such as probiotics, to treat neurological conditions.

 

The Gut-Brain Communication Pathways and their Role in Neurological Disorders

The gut-brain axis refers to the bidirectional communication between the gut and the CNS, and plays a crucial role in maintaining overall health and wellness. The gut-brain communication pathways can be divided into three broad categories: neural, hormonal, and immune (15, 16).

The neural pathways of the gut-brain axis involve direct communication between the enteric nervous system (ENS), which is responsible for controlling gut motility, and the CNS. The ENS and CNS are connected via the vagus nerve, which allows for the transfer of sensory and motor signals between the two systems (17). The vagal nerve also modulates the release of several neurotransmitters, including acetylcholine, dopamine, and norepinephrine, which can impact the brain and behavior (18).

The hormonal pathways of the gut-brain axis involve the release of hormones from the gut into the bloodstream, which can then act on the brain to modulate behavior and physiological processes. For example, gut hormones such as ghrelin and leptin play important roles in regulating energy balance and food intake, and have been implicated in the pathogenesis of several neurological conditions, including obesity, depression, and anxiety (19).

The immune pathways of the gut-brain axis involve the interaction between the gut microbiome and the immune system. The gut microbiome can influence the immune system by modulating the production of cytokines and other signaling molecules, which can impact the brain and behavior (20). Additionally, changes in the gut microbiome can lead to an increase in gut permeability, allowing for the presence of low-grade inflammation, which has been linked to the development of several neurological conditions, including depression, anxiety, and autism (21).

There is growing evidence to suggest that imbalances in the gut-brain communication pathways can contribute to the development and progression of neurological disorders. For instance, alterations in the neural pathways have been observed in individuals with depression, and the administration of drugs that modulate the release of neurotransmitters has been shown to improve symptoms in some patients (22, 23). Additionally, imbalances in the hormonal pathways have been implicated in the pathogenesis of obesity and diabetes, while alterations in the immune pathways have been linked to the development of autism and other neurological conditions.

In conclusion, the gut-brain communication pathways play a critical role in maintaining overall health and wellness. Imbalances in these pathways can contribute to the development and progression of neurological disorders, and further research is needed to better understand the mechanisms by which the gut-brain axis influences the brain and behavior (24, 25). By gaining a deeper understanding of the gut-brain communication pathways, we may be able to develop new and innovative treatments for a range of neurological conditions.

 

Gut-Microbiome Imbalances and Neurological Disorders: The Role of Dysbiosis

The gut microbiome plays a crucial role in maintaining overall health and wellness, and imbalances in the gut microbiome have been implicated in the development of a number of neurological disorders. Dysbiosis, which refers to an imbalance in the composition of the gut microbiome, has been shown to impact the gut-brain communication pathways, leading to changes in brain function and behavior (26).

One of the ways in which dysbiosis can contribute to the development of neurological disorders is by altering the gut-brain communication pathways. For example, imbalances in the gut microbiome can result in changes in the release of neurotransmitters, hormones, and cytokines, which can impact the brain and behavior (17, 18). Additionally, imbalances in the gut microbiome can lead to increased gut permeability, allowing for the presence of low-grade inflammation, which has been linked to the development of several neurological conditions, including depression, anxiety, and autism.

Dysbiosis has also been linked to several specific neurological disorders. For example, alterations in the gut microbiome have been observed in individuals with Parkinson's disease, and evidence suggests that changes in the gut microbiome may contribute to the development of this condition (11, 20). Additionally, imbalances in the gut microbiome have been implicated in the pathogenesis of multiple sclerosis, and there is evidence to suggest that alterations in the gut microbiome may play a role in the development and progression of this disease.

Overall, dysbiosis, or an imbalance in the composition of the gut microbiome, can contribute to the development and progression of several neurological disorders (26). Further research is needed to better understand the mechanisms by which gut-microbiome imbalances impact the brain and behavior, and to develop new and innovative treatments for a range of neurological conditions. By understanding the role of dysbiosis in neurological disorders, we may be able to improve our ability to diagnose, treat, and prevent these conditions.

 

Gut-Directed Therapies for Neurological Disorders: Probiotics, Prebiotics, and Fecal Microbiota Transplantation

The recognition of the role of gut-microbiome imbalances in the development and progression of neurological disorders has led to the development of several gut-directed therapies for these conditions. Probiotics, prebiotics, and fecal microbiota transplantation are three such therapies that have been shown to impact the gut microbiome and improve brain function and behavior (27).

Probiotics are live microorganisms that are taken as dietary supplements or found in fermented foods, and they have been shown to improve gut health by restoring the balance of the gut microbiome. There is a growing body of evidence suggesting that probiotics may be beneficial for individuals with a range of neurological disorders, including depression, anxiety, and autism. In several studies, probiotics have been shown to impact brain function and behavior, and to reduce symptoms in individuals with these conditions (24, 28).

Prebiotics are non-digestible food ingredients that promote the growth of beneficial bacteria in the gut, and they have also been shown to improve gut health (29). There is evidence to suggest that prebiotics may be beneficial for individuals with a range of neurological disorders, including depression and anxiety. In several studies, prebiotics have been shown to impact brain function and behavior, and to reduce symptoms in individuals with these conditions.

Fecal microbiota transplantation (FMT) is a gut-directed therapy that involves the transplantation of healthy gut bacteria from one individual to another (30). This procedure has been shown to be effective in restoring the balance of the gut microbiome, and there is evidence to suggest that it may be beneficial for individuals with neurological disorders. In several studies, FMT has been shown to impact brain function and behavior, and to reduce symptoms in individuals with conditions such as depression, anxiety, and autism (31).

At the end, probiotics, prebiotics, and fecal microbiota transplantation are three gut-directed therapies that have been shown to impact the gut microbiome and improve brain function and behavior in individuals with neurological disorders (32). Further research is needed to better understand the mechanisms by which these therapies impact the brain and behavior, and to determine their effectiveness for a range of neurological conditions. However, these therapies hold great promise for the future treatment of neurological disorders, and they represent a promising new direction in the management of these conditions.

 

 

Future Directions and Challenges in Gut-Brain Research for Neurological Disorders

The recognition of the role of the gut-brain axis in the development and progression of neurological disorders has led to a growing interest in this field of research. Despite the growing body of evidence supporting the role of the gut microbiome in neurological disorders, there are several challenges and limitations that need to be addressed in order to advance this field of research.

One of the major challenges in gut-brain research for neurological disorders is the lack of standardized and validated methods for measuring gut microbiome composition and function. This makes it difficult to compare results across studies and to determine the impact of gut-directed therapies on the gut microbiome and brain function. There is a need for the development of standardized and validated methods for measuring the gut microbiome, in order to advance this field of research.

Another major challenge in gut-brain research for neurological disorders is the complexity of the gut-brain axis and the multitude of factors that can impact gut microbiome composition and function. This complexity makes it difficult to determine the specific mechanisms by which the gut microbiome impacts the brain and behavior, and to determine the specific gut-directed therapies that are most effective for a given neurological disorder.

Despite these challenges, there is a growing interest in gut-brain research for neurological disorders, and there is a growing body of evidence supporting the role of the gut microbiome in these conditions. In the future, it is likely that this field of research will continue to grow and evolve, and that new and innovative therapies will be developed for the treatment of neurological disorders.

 

Conclusion

We can conclude that the field of gut-brain research for neurological disorders holds great promise for the future, and it represents a new and exciting direction in the management of these conditions. However, there are several challenges and limitations that need to be addressed in order to advance this field of research and to determine the specific mechanisms by which the gut microbiome impacts the brain and behavior. Nevertheless, the future of gut-brain research for neurological disorders is bright, and it holds great promise for improving the lives of individuals with these conditions.

 

Deceleration

 

Funding

We do not have any financial support for this study.

 

Conflict of interest

The author declares no conflict of interest regarding the publication of this paper.

 

Ethical approval

Not applicable

 

Availability of data and material

The datasets analyzed during the current study are available upon request with no restriction.

 

Consent for publication

This manuscript has been approved for publication by all authors.

1. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2011;60(3):307-17.
https://doi.org/10.1136/gut.2009.202515
PMid:20966022
 
2. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016;167(4):915-32.
https://doi.org/10.1016/j.cell.2016.10.027
PMid:27814521 PMCid:PMC5127403
 
3. Nishino R, Mikami K, Takahashi H, Tomonaga S, Furuse M, Hiramoto T, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25(6):521-8.
https://doi.org/10.1111/nmo.12110
PMid:23480302
 
4. Kim KS. Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention. Curr Opin Infect Dis. 2012;25(3):273-8.
https://doi.org/10.1097/QCO.0b013e3283521eb0
PMid:22395761
 
5. Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15-25.
https://doi.org/10.1016/j.biopsych.2013.01.007
PMid:23419545
 
6. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165(6):1332-45.
https://doi.org/10.1016/j.cell.2016.05.041
PMid:27259147
 
7. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: A review. Ann Neurol. 2017;81(3):369-82.
https://doi.org/10.1002/ana.24901
PMid:28220542
 
8. Gagliani N, Palm NW, de Zoete MR, Flavell RA. Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota. Int Immunol. 2014;26(9):495-9.
https://doi.org/10.1093/intimm/dxu066
PMid:24948595 PMCid:PMC4200027
 
9. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-5.
https://doi.org/10.1073/pnas.1102999108
PMid:21876150 PMCid:PMC3179073
 
10. Truax AD, Chen L, Tam JW, Cheng N, Guo H, Koblansky AA, et al. The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe. 2018;24(3):364-78.e6.
https://doi.org/10.1016/j.chom.2018.08.009
PMid:30212649 PMCid:PMC6161752
 
11. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-73.
https://doi.org/10.1126/science.1223490
PMid:22674334 PMCid:PMC4420145
 
12. Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20(2):145-55.
https://doi.org/10.1038/nn.4476
PMid:28092661 PMCid:PMC6960010
 
13. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599-609, .e1-3.
https://doi.org/10.1053/j.gastro.2011.04.052
PMid:21683077
 
14. Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351(6279):1296-302.
https://doi.org/10.1126/science.aad2571
PMid:26989247
 
15. Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6:6734.
https://doi.org/10.1038/ncomms7734
PMid:25828455
 
16. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107-33.
https://doi.org/10.1146/annurev.mi.31.100177.000543
PMid:334036
 
17. Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, et al. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018;9(1):3674.
https://doi.org/10.1038/s41467-018-06048-w
PMid:30201970 PMCid:PMC6131147
 
18. Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271-85.
https://doi.org/10.1038/nrc.2017.13
PMid:28303904
 
19. Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Groß U, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol. 2013;2013:526860.
https://doi.org/10.1155/2013/526860
PMid:24324507 PMCid:PMC3845433
 
20. Ferreiro A, Crook N, Gasparrini AJ, Dantas G. Multiscale Evolutionary Dynamics of Host-Associated Microbiomes. Cell. 2018;172(6):1216-27.
https://doi.org/10.1016/j.cell.2018.02.015
PMid:29522743 PMCid:PMC5846202
 
21. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell. 2010;141(3):483-96.
https://doi.org/10.1016/j.cell.2010.03.040
PMid:20434986 PMCid:PMC3150216
 
22. Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, et al. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings. Brain Behav Immun. 2017;64:367-83.
https://doi.org/10.1016/j.bbi.2017.03.002
PMid:28263786
 
23. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-52.
https://doi.org/10.1073/pnas.1010529108
PMid:21282636 PMCid:PMC3041077
 
24. Thabane M, Simunovic M, Akhtar-Danesh N, Garg AX, Clark WF, Collins SM, et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol. 2010;105(4):933-9.
https://doi.org/10.1038/ajg.2010.74
PMid:20179687
 
25. Barichello T, Fagundes GD, Generoso JS, Elias SG, Simões LR, Teixeira AL. Pathophysiology of neonatal acute bacterial meningitis. J Med Microbiol. 2013;62(Pt 12):1781-9.
https://doi.org/10.1099/jmm.0.059840-0
PMid:23946474
 
26. Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol. 2013;39(3):229-46.
https://doi.org/10.3109/1040841X.2012.706249
PMid:22866947
 
27. Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol. 2017;18(8):851-60.
https://doi.org/10.1038/ni.3780
PMid:28722709 PMCid:PMC5800875
 
28. Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014;169:15-20.
https://doi.org/10.1016/j.jad.2014.07.032
PMid:25128861
 
29. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41.
https://doi.org/10.1016/j.cell.2014.03.011
PMid:24679531 PMCid:PMC4056765
 
30. Mitchell AM, Mitchell TJ. Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect. 2010;16(5):411-8.
https://doi.org/10.1111/j.1469-0691.2010.03183.x
PMid:20132250
 
31. Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. 2017;7:124-36.
https://doi.org/10.1016/j.ynstr.2017.03.001
PMid:29276734 PMCid:PMC5736941
 
32. Smith PA. The tantalizing links between gut microbes and the brain. Nature. 2015;526(7573):312-4.
https://doi.org/10.1038/526312a
PMid:26469024
Volume 2, Issue 1
April 2023
Pages 25-29
  • Receive Date: 21 February 2023
  • Accept Date: 08 March 2023